◆ 会议时间:2023年9月24-27日
◆ 会议地点:挪威 奥斯陆
◆ 会议简介:
2023年第21届国际治疗药物监测与临床毒理学大会将于2023年9月24-27日在挪威奥斯陆举行,会议由国际治疗药物监测与临床毒理学会(IATDMCT)主办。IATDMCT大会将汇集世界一流的从事治疗药物监测和临床毒理学工作的科学家和医疗保健专业人士,为与会的研究人员和临床医生提供一个分享他们在基础、临床和转化药理学和临床毒理学方面研究和经验的机会。与会者包括:药物分析专家、临床药理学家、临床毒理学家、医生、药剂师、实验室化学家等。
国际治疗药物监测与临床毒理学会(IATDMCT)成立于1990年,是全球唯一的致力于推动全球治疗药物监测和临床毒理学相关学科发展的国际组织,由来自全球 70多个国家的科学家和临床医生组成,在促进治疗药物监测和临床毒理学研究与实践方面,IATDMCT在国际上具有独一无二的地位。IATDMCT的目标是促进和提升治疗药物监测和临床毒理学的教育和研究;提高药物和毒性物质分析的实践和临床判读标准,并通过临床药代动力学和毒代动力学促进判读的传递,以加强患者护理;促进与治疗药物监测和临床毒理学有关的所有专业人士间宣的合作;促进有效应用治疗药物监测,优化临床用药,最大限度地提高临床效果和经济效益;支持将在临床毒理学方面取得的进展,作为治疗药物过量、滥用药物和接触环境毒物的诊断工具和治疗辅助手段。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
IATDMCT 2023
21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2023
Dates: September 24-27, 2023
Venue: Oslo, Norway
摘要征文投稿:
Deadline for submitting abstract: 15. April 2023.
Submit now!
All abstracts must be submitted electronically only through this website. Abstracts submitted via e-mail or regular mail will neither be accepted nor acknowledged.
Deadline for submitting abstract: 15. April 2023.
All submitted abstracts will be peer-reviewed and assigned to appropriate session. Notification on acceptance will be sent to the submitter by email by early June 2023. Accepted contributions will be selected into two groups for presentation; poster or oral presentation.
Specific topics for include, but are not limited to:
- Immunosuppression
- Anti-infectives - antivirals
- Anti-infectives - antibiotics and antifungals
- Oncology
- Biologicals
- Psychiatry
- Clinical toxicology and drugs of misuse
- Toxicology and environmental health
- Alternative sampling strategies
- Pharmacogenetics
- Pharmacometrics
- Micellanous
Guidelines for submitting an abstract
If accepted for poster or oral presentation, the presenting author should register for the conference by June 15th to benefit from the Early Bird price. If the presenter does not register, the presentation will be cancelled.
Submission
The conference language is English, and abstract submission is possible in English only.
Indicate if you prefer poster presentation. Otherwise, the scientific committee will decide whether your paper will be accepted as an oral presentation or poster.
Please note that only the submitting (corresponding) author receives all abstract notifications. Make sure that emails from IATDMCT@gyro.no are not marked as spam by your email provider.
The submitting (corresponding) author takes responsibility for informing all co-authors about successful submission, acceptance or rejection and forwards the received instructions for the presentation of the abstract to the presenting author.
Abstract contents and format
Do not use the title or the name(s) of the author(s) in the body of the abstract.
Please organize the abstract as follows:
- Introduction
- Materials and Methods
- Results
- Discussions and Conclusions
Maximum length of the abstract is max. 500 words.
Use text only in the abstract, do not include images or tables. Please use a minimum of formatting for abstracts. We cannot guarantee that abstracts will be formatted in the exact way as they are entered.
Submitted abstracts must be original. Abstracts previously published or presented at an international scientific meeting cannot be submitted. All submissions will be peer reviewed.
Avoid using non-standard abbreviations or define them when they first appear in the text.
Abstract will be published in the TDM Journal
Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, pathology, toxicology, analytical chemistry–that share a common interest in Therapeutic Drug Monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Therapeutic Drug Monitoring is interested in clinical studies that assess and establish pharmacokinetics/pharmacodynamics or toxicokinetics/toxicodynamics relationships. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles. Therapeutic Drug Monitoring is the official Journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Welcome
It is a great pleasure to welcome you to the 21st Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2023 in Oslo. The congress venue Oslo Congress Centre is located in the heart of Oslo, within walking distance from a range of hotels as well as the Oslo Central Station with frequent communications to the Oslo Airport (OSL).
The slogan for our congress is “Personalized under the Northern Sky”, which hints you to the presentation of some currently hot topics in Scandinavia in addition to the themes that are important and obligatory for our association. The IATDMCT Congress provides an opportunity for promoting, updating and learning the science and clinical practice of Therapeutic Drug Monitoring and Clinical Toxicology. The program includes TDM and personalized treatment in therapeutic areas like cardiovascular drugs including statins, biologicals in rheumatology, antivirals and other anti-infectives, immunosuppressives, antipsychotics and more. There will be sessions on pharmacogenetics, pharmacometrics plus machine learning and AI, advancements in relevant analytical techniques, analyses related to toxic plants, doping control and toxicity of recreational drug and new psychoactive substances. We are also planning a pre-congress symposium on microsampling and patients' home sampling including hands-on practice.
As characterized in the VisitOslo guide , Oslo is nowadays a city that pulsates, changes and moves; there's always something new to explore. Several of the described recent highlights from the Norwegian capital can be reached with a few minutes walk from the venue and the hotels.
We look forward to meeting you in Oslo in September –colleagues, members of the IATDMCT as well as non-members of any profession with interest in the listed topics.
Yours Sincerely
Prof. Stein Bergan
Chair, IATDMCT 2023 Oslo Congress
Dept. of Pharmacology, Oslo University Hospital & University of Oslo
注册费:
CONGRESS
|
Early registation
(until June 15th) |
Regular registration
(from June 15th to September 10th) |
On-site registration
(from September 10th) |
IATDMCT Member |
5400 |
6300 |
7200 |
IATDMCT Non-member |
7200 |
8200 |
9000 |
IATDMCT Member Young Scientist * |
3800 |
4700 |
5600 |
Student ** |
2700 |
3200 |
3600 |
Congress dinner September 26th |
800 |
800 |
800 |
Breakfast Round table session |
300 |
300 |
300 |
Accompanying person *** |
1950 |
1950 |
1950 |
PRE-CONGRESS SEPTEMBER 24th
|
Early registation
(until June 15th) |
Regular registration
(from June 15th to September 10th) |
On-site registration
(from September 10th) |
IATDMCT Member |
700 |
900 |
1100 |
IATDMCT Non-member |
900 |
1100 |
1400 |
IATDMCT Member Young Scientist * |
500 |
700 |
800 |
Student ** |
300 |
400 |
500 |
All prices displayed on this page are in Norwegian Kroner (NOK) and taxes are included. The registration fees include all lunches and breaks, Welcome reception (on Sunday) and the reception on Monday.
* Only applicable for Young Scientists Members (31–40 years) and for Junior members (up to 30 years). Confirmation of age must be provided to congress secretariat on request.
** Only applicable for PhD candidates or students enrolled to Universities, Academies, Educational Institutes, Schools or Master’s Degrees. Certificate of study must be provided to secretary upon request.
*** Accompanying person is not a conference participant. The fee includes the social aspects of the conference and does not include any parts of the scientific program.
◆ 参会对象:药物分析专家、临床药理学家、临床毒理学家、医生、药剂师、实验室化学家以及其他对该领域感兴趣的相关专业人士代表等等。
|